Author

Michael Khalil

Medical University of GrazORCID 0000-0002-5350-3328Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Antonio Heras‐GarviniD· 1 shared Charles Anthony DinarelloiD· 1 shared Damaris B. Skouras· 1 shared Jesús Amo‐AparicioiD· 1 shared Kelvin C. LukiD· 1 shared Magdalena Matic· 1 shared María LuqueiD· 1 shared Michaela Tanja HaindliD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Antonio Heras‐GarvinORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Pharmacologic NLRP3 Inhibition Modulates Parkinson's Disease-Associated Microglial Transcriptomic Signatures and Mitigates α-Synuclein-Triggered Neurodegeneration

María Luque, Magdalena Matic, Antonio Heras‐Garvin, Jesús Amo‐Aparicio, Kelvin C. Luk, Michaela Tanja Haindl, Michael Khalil, Damaris B. Skouras, Charles Anthony Dinarello, Nadia Stefanova

This study evaluates dapansutrile, an NLRP3 inhibitor, in preclinical models of Parkinson's disease and multiple system atrophy, showing improved motor function, reduced neurodegeneration, and transcriptomic changes in microglia.

Journal of Neuroinflammation · Jan 31, 2026Peer-reviewedNeuroscience